secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2022-05-17T23:59:59+00:00
Accession:  0001213900-22-027465
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx authorizes $20M share repurchase program through May 2023
--------------------------------------------------------------------

- Board authorized repurchase of up to $20M of outstanding common stock.
- Repurchases may occur in open market or private transactions; program expires May 17, 2023 or when $20M is reached.
- Company will finance buybacks using available cash and cash equivalents.
- Board may modify, suspend, extend or terminate the program at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390022027465/0001213900-22-027465-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390022027465/ea160087-8k_optimizerx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-027465

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer